TUE Mar 9, 04, 2:15 AM Mar 9, 2004
Rituxan(R) is a registered trademark of IDEC Pharmaceuticals Corporation. For further information, please contact: GPC Biotech AG Fraunhoferstr. (PR Newswire)
GPC Biotech Reports Financial Results for First Quarter 2004 Apr 30, 2004
Rituxan(R) is a registered trademark of IDEC Pharmaceuticals Corporation. TAXOL(R) is a registered trademark of Bristol-Myers Squibb Company. (Yahoo News)
Biogen Idec Reports First Quarter 2004 Earnings per Share of ... Apr 30, 2004
Adjusted pro forma non-GAAP earnings per share and net income for the first quarter of 2003 include revenue and expenses from the former Biogen, Inc. from January 1 to March 31, 2003 but excludes all other non-operating charges of former Biogen, Inc. and IDEC Pharmaceuticals Corporation. These adjustments, expenses, and non-operating charges are itemized on the attached reconciliation tables. (Yahoo News)
Biogen Idec Chief Operating Officer William Rohn to Retire Nov 30, 2004
D., Biogen Idec's Executive Chairman, said, "Through his vision, commitment, and strong leadership over more than a decade, Bill Rohn helped transform IDEC Pharmaceuticals Corporation from a small research organization into a very successful biotechnology company. Bill then played an instrumental role in the formation of Biogen Idec, a global biotechnology leader. We thank him for his countless contributions. He has been a great colleague and will be missed." ... Prior to the merger of IDEC... (Yahoo Finance -- Biotechnology & Drugs)
Orange 21 Appoints General Counsel Feb 8, 2005
Previously, Ms. Meier served as Vice President and General Counsel for Senomyx, Inc. and corporate counsel at IDEC Pharmaceuticals Corporation, now Biogen Idec, Inc., and handled litigation for American International Group, Inc., Mentor Corporation and Holidays Inns, Inc. Ms. Meier holds a B.A. from St. Leo University and a Law Degree from California Western School of Law. About Orange 21. (Yahoo Finance -- Recreational Products)
Illumina Names William Rastetter Chairman of Board and Appoints John Stuelpnagel Chief Operating Officer Jan 28, 2005
Before the 2003 merger of IDEC Pharmaceuticals Corporation and Biogen, Inc., he was Chairman and CEO of IDEC Pharmaceuticals Corporation, where he served since 1986 in a number of senior positions. Dr. Rastetter worked at Genentech from 1982-1986, and was previously an associate professor of chemistry at the Massachusetts Institute of Technology. (Yahoo Finance -- Scientific & Technical Instr.)
